ABOUT THE PRODUCT
A proprietary platform utilizing organoids and machine learning to predict drug efficacy and patient response in cancer treatment. This service enables faster and more accurate identification of promising drug candidates.
Information is owner-confirmed
Last updated 1 week ago
Price range
Other products/services from Xilis
Precision Oncology Modeling Services
Biotechnology
N/A
Xilis
United States (US)